Frank Reynolds (file photo)
October 29, 2019 06:05 AM EDTUpdated 08:29 AM
People

Boston ju­ry finds biotech CEO guilty of fleec­ing in­vestors, ob­struc­tion of jus­tice

Jason Mast

Editor

The biotech CEO who promised to end “thou­sands of years of mor­phine and opi­ate ad­dic­tion” and al­leged­ly told in­vestors they could re­al­ize huge gains by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times